insights_auto
ALNOV āĻā§āύ āĻāĻŽā§āĻ⧠⧍.ā§Šā§¯%?
āĻāϰāĻ āĻāĻā§āϰ⧠āĻāĻŋā§ā§ āĻāĻžāύā§āύchevron_right
ALNOV:EPA
Novacyt SA
ā§Ļ.ā§Ēā§ŠâŦ
arrow_downward
-⧍.ā§Šā§¯%(-ā§Ļ.ā§Ļā§§ā§Ļ) ā§§ āĻĻāĻŋ
⧍ā§Ļ āύāĻā§, ā§§ā§Ļ:⧍ā§Ģ:ā§§ā§§ AM GMT +ā§§ · EUR
search
āϏāĻŦ āϏāĻŋāĻŽā§āĻŦāϞ
| āϏāĻŋāĻŽā§āĻŦāϞ | āĻĻāĻžāĻŽ | āĻĒāϰāĻŋāĻŦāϰā§āϤāύ āĻāϰā§āύ | % āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|
insights_autoALNOV-āĻāϰ āĻāύā§āϝ āϏā§āϰāĻž āĻāύāϏāĻžāĻāĻ āĻā§āύāĻžāϰā§āĻ āĻāϰāĻž āĻšāĻā§āĻā§...
āĻā§āϞā§āύ
ā§Ļ.ā§Ēā§ŠâŦ
āϏāϰā§āĻŦāĻžāϧāĻŋāĻ
ā§Ļ.ā§Ēā§ĒâŦ
āϏāϰā§āĻŦāύāĻŋāĻŽā§āύ
ā§Ļ.ā§Ēā§ŠâŦ
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
ā§Š.ā§§ā§§Â āĻā§
āĻ
ā§āϝāĻžāĻāĻžāϰā§āĻ āĻāϞāĻŋāĻāĻŽ
ā§§.ā§¨ā§ŽÂ āϞāĻž
āĻāϞāĻŋāĻāĻŽ
ā§§ā§Ļ.ā§Ēā§Ē āĻšāĻž
ā§Ģ⧍ āϏāĻĒā§āϤāĻžāĻšā§āϰ āϏāϰā§āĻŦā§āĻā§āĻ āĻĻāĻžāĻŽ
ā§§.ā§Ļā§ĒâŦ
ā§Ģ⧍ āϏāĻĒā§āϤāĻžāĻšā§āϰ āϏāϰā§āĻŦāύāĻŋāĻŽā§āύ āĻĻāĻžāĻŽ
ā§Ļ.⧍⧝âŦ
EPS
-ā§Ļ.ā§Šā§ŽâŦ
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ
ā§.⧍ā§Ŧ āĻā§
āĻāϰā§āĻŽā§āϏāĻāĻā§āϝāĻž
ā§¨ā§¨ā§Ž
āĻā§āϞā§āύ
ā§Ļ.ā§Ēā§ŠâŦ
āϏāϰā§āĻŦāĻžāϧāĻŋāĻ
ā§Ļ.ā§Ēā§ĒâŦ
āϏāϰā§āĻŦāύāĻŋāĻŽā§āύ
ā§Ļ.ā§Ēā§ŠâŦ
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
ā§Š.ā§§ā§§Â āĻā§
āĻ
ā§āϝāĻžāĻāĻžāϰā§āĻ āĻāϞāĻŋāĻāĻŽ
ā§§.ā§¨ā§ŽÂ āϞāĻž
āĻāϞāĻŋāĻāĻŽ
ā§§ā§Ļ.ā§Ēā§Ē āĻšāĻž
ā§Ģ⧍ āϏāĻĒā§āϤāĻžāĻšā§āϰ āϏāϰā§āĻŦā§āĻā§āĻ āĻĻāĻžāĻŽ
ā§§.ā§Ļā§ĒâŦ
ā§Ģ⧍ āϏāĻĒā§āϤāĻžāĻšā§āϰ āϏāϰā§āĻŦāύāĻŋāĻŽā§āύ āĻĻāĻžāĻŽ
ā§Ļ.⧍⧝âŦ
EPS
-ā§Ļ.ā§Šā§ŽâŦ
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ
ā§.⧍ā§Ŧ āĻā§
āĻāϰā§āĻŽā§āϏāĻāĻā§āϝāĻž
ā§¨ā§¨ā§Ž
āĻāĻŦāϰā§āϰ āϏā§āĻā§āϰāĻŋ
āĻā§ā§āĻŦ āϏā§āϰā§āϏ āĻ āĻāĻŦāϰā§āϰ āĻĒāĻžāϰā§āĻāύāĻžāϰāĻĻā§āϰ āĻĨā§āĻā§
The Motley Fool
·
ā§Šā§¯ āĻŽāĻŋāύāĻŋāĻ āĻāĻā§
Nvidia Has Lost More Than the Market Value of 495 S&P 500 Companies in 6 Weeks -- and Its Downtrend May Be Just Beginning
Yahoo Finance
·
ā§§ā§ āĻŽāĻŋāύāĻŋāĻ āĻāĻā§
Stock market today: Dow, S&P 500, Nasdaq futures continue to sell-off after Anthropic IPO fails to quell AI worries
BeInCrypto
·
ā§Ēā§Ŧ āĻŽāĻŋāύāĻŋāĻ āĻāĻā§
S&P 500 Logs Its Longest Losing Streak Since 2024. Hereâs What Happened Last Time
Investing.com
·
ā§§ āĻāĻŖā§āĻāĻž āĻāĻā§
S&P 500 Breaks Support as Global Risk Sentiment Begins to Crack
āĻĒā§āϰā§āĻĢāĻžāĻāϞ
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and VÊlizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Novacyt SA āϏāĻŽā§āĻĒāϰā§āĻā§
āϏāĻŋāĻāĻāĻĄā§āĻāĻŋāĻĄ āĻ
ā§āϝāĻžāϞāĻŽāύā§āĻĄ
āĻāϰā§āĻŽā§ā§¨ā§¨ā§Ž
āĻĒā§āϰāϤāĻŋāώā§āĻ āĻžāϰ āϤāĻžāϰāĻŋāĻā§Š āĻā§āϞ, ⧍ā§Ļā§Ļā§Ŧ
āĻšā§āĻĄāĻā§ā§āĻžāϰā§āĻāĻžāϰ-
āϏā§āĻā§āĻāϰHealth Care
āĻāύā§āĻĄāĻžāϏā§āĻā§āϰāĻŋ-
āĻā§ā§āĻŦāϏāĻžāĻāĻnovacyt.com